Skip to main content
. 2021 Feb 1;14(2):113. doi: 10.3390/ph14020113

Table 3.

The eight designed drug-SLNs according to 23-factorial design.

SNP Formulation No. X1 X2 X3
A: Lipid Type B: Surfactant Lipid C: Surfactant Conc. (% w/v)
1 COMP Cremophor RH40 1.5
2 COMP Cremophor RH40 1
3 COMP Poloxamer 188 1
4 GMS Cremophor RH40 1
5 COMP Poloxamer 188 1.5
6 GMS Cremophor RH40 1.5
7 GMS Poloxamer 188 1
8 GMS Poloxamer 188 1.5